Form 4 for IMNM Immunome Inc.
Accepted 2026-07-09 17:38:38 ET · period of report 2026-07-07 · accession 0001831215-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-07-09 17:38 | 2026-07-07 | IMNM | Horn Kinney | Chief BUSINESS Off | M - OptEx | $12.92 | +1,092 | 1,092 | New | +$14.1K |
| DT | 2026-07-09 17:38 | 2026-07-07 | IMNM | Horn Kinney | Chief BUSINESS Off | S - Sale+OE | $25.00 | -1,092 | 0 | -100% | -$27.3K |
| DT | 2026-07-09 17:38 | 2026-07-07 | IMNM | Horn Kinney | Chief BUSINESS Off | M - OptEx | $0.00 | -1,092 | 128.9K | -0.8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-07 | M | A | 1,092 | $12.92 | 1,092 | D | — | — | |
| 2 | Common | Common Stock | 2026-07-07 | S | D | 1,092 | $25.00 | 0 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 30, 2026. |
| 3 | Derivative | Employee Stock Option (right to buy) | 2026-07-07 | M | D | 1,092 | $0.00 | 128,908 | D | $12.92 · — to 2034-08-08 | 1,092 Common Stock | (F2) 25% of the shares subject to the option vested on August 9, 2025, and the remaining shares will vest monthly thereafter over three years. |